These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30788537)

  • 1. [National immunization program initiatives-What are their contribution to the elimination of measles and rubella in Germany?].
    Kouros B; Nennstiel U; Liebl B; Ludwig MS
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Apr; 62(4):386-391. PubMed ID: 30788537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
    Limia Sánchez A; Molina Olivas M
    Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
    Orenstein WA; Hinman A; Nkowane B; Olive JM; Reingold A
    Vaccine; 2018 Jan; 36 Suppl 1():A1-A34. PubMed ID: 29307367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activities to catch up and Vaccinate the Susceptible Population in Valencian Community, Spain].
    Martín-Ivorra R; Alguacil-Ramos AM; Lluch-Rodrigo JA; Pastor-Villalba E; Portero-Alonso A
    Rev Esp Salud Publica; 2015; 89(4):419-26. PubMed ID: 26580797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.
    Richardson LC; Moss WJ
    Pan Afr Med J; 2020; 35(Suppl 1):3. PubMed ID: 32373254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles and rubella elimination in the Eastern Mediterranean Region: successes and challenges.
    Teleb N; Atta H; Hajjeh R
    East Mediterr Health J; 2019 Nov; 25(10):667-668. PubMed ID: 31774131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the elimination of measles and congenital rubella in Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Panatto D; Amicizia D; Bonanni P
    Hum Vaccin Immunother; 2013 Mar; 9(3):649-56. PubMed ID: 23292174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The end of measles and congenital rubella: an achievable dream?
    Adamo G; Sturabotti G; D'Andrea E; Baccolini V; Romano F; Iannazzo S; Marzuillo C; Villari P
    Ann Ig; 2017; 29(1):1-26. PubMed ID: 28067934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM; Sabbour SM; Dewedar SA
    Vaccine; 2010 Nov; 28(47):7563-8. PubMed ID: 20797454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.
    Fields R; Dabbagh A; Jain M; Sagar KS
    Vaccine; 2013 Apr; 31 Suppl 2():B115-21. PubMed ID: 23598472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
    Wichmann O; Ultsch B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.